FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Reinhard Stauder

Research Profile

Chemicals & Drugs

Disorders

Anatomy

Physiology

Procedures

Antineoplastic Combined Chemotherapy Protocols

Concepts & Ideas

Co-author Network

Publications

TOP 3
Christine Valentiny; Wolfgang Willenbacher; Martina Mitrovic; Lisa Pleyer; Michael Steurer; Reinhard Stauder
Complete remission after a single cycle of azacitidine in a case of relapsed acute myeloid leukemia.
Reinhard Stauder
The challenge of individualised risk assessment and therapy planning in elderly high-risk myelodysplastic syndromes (MDS) patients.
Julie Schanz; Marilyn L Slovak; Francesc Solé; Reinhard Stauder; Christian Steidl; Heinz Tüchler; Peter Valent; Carlo Aul; John M Bennett; José Cervera; Stefan Faderl; Christa Fonatsch; Guillermo Garcia-Manero; Ulrich Germing; Aristoteles Giagounidis; Isabel Granada; Peter Greenberg; Barbara Hildebrandt; Otto Krieger; Michelle M Le Beau; Michael Lübbert; Elisa Luño; Mar Mallo; Thomas Nösslinger; Kazuma Ohyashiki; Michael Pfeilstöcker; Sherry Pierce; Detlef Haase
New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Reinhard Stauder (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Christine Valentiny; Wolfgang Willenbacher; Martina Mitrovic; Lisa Pleyer; Michael Steurer; Reinhard Stauder
Complete remission after a single cycle of azacitidine in a case of relapsed acute myeloid leukemia.
Wiener klinische Wochenschrift 2013;125(1-2):50-3.
2012: Reinhard Stauder
The challenge of individualised risk assessment and therapy planning in elderly high-risk myelodysplastic syndromes (MDS) patients.
Annals of hematology 2012;91(9):1333-43.
2012: Julie Schanz; Marilyn L Slovak; Francesc Solé; Reinhard Stauder; Christian Steidl; Heinz Tüchler; Peter Valent; Carlo Aul; John M Bennett; José Cervera; Stefan Faderl; Christa Fonatsch; Guillermo Garcia-Manero; Ulrich Germing; Aristoteles Giagounidis; Isabel Granada; Peter Greenberg; Barbara Hildebrandt; Otto Krieger; Michelle M Le Beau; Michael Lübbert; Elisa Luño; Mar Mallo; Thomas Nösslinger; Kazuma Ohyashiki; Michael Pfeilstöcker; Sherry Pierce; Detlef Haase
New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(8):820-9.
2011: Julie Schanz; Christian Steidl; Christa Fonatsch; Michael Pfeilstöcker; Thomas Nösslinger; Heinz Tuechler; Peter Valent; Barbara Hildebrandt; Aristoteles Giagounidis; Carlo Aul; Michael Lübbert; Reinhard Stauder; Otto Krieger; Guillermo Garcia-Manero; Hagop Kantarjian; Ulrich Germing; Detlef Haase; Elihu Estey
Coalesced multicentric analysis of 2,351 patients with myelodysplastic syndromes indicates an underestimation of poor-risk cytogenetics of myelodysplastic syndromes in the international prognostic scoring system.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(15):1963-70.
2011: Christian Waldthaler; August Zabernigg; Günther Zangerl; Günther Gastl; Judith Hager; Horst Oexle; Michael Schnallinger; Stephan Schreieck; Reinhard Stauder; Irmgard Verdorfer; Michael Fiegl
Routine use of bendamustine and rituximab combination therapy in consecutive patients with lymphoproliferative diseases: a survey from Tyrolean hospitals.
Wiener klinische Wochenschrift 2011;123(9-10):269-75.
2011: Judith Loeffler-Ragg; U Germing; Wolfgang R Sperr; H Herrmann; Heinz Zwierzina; Peter Valent; Hanno Ulmer; Reinhard Stauder
Serum CD44 levels predict survival in patients with low-risk myelodysplastic syndromes.
Critical reviews in oncology/hematology 2011;78(2):150-61.
2010: Reinhard Stauder; K Moser; Bernhard Holzner; B Sperner-Unterweger; G Kemmler
Six independent domains are defined by geriatric assessment in elderly cancer patients.
Critical reviews in oncology/hematology 2010;74(2):97-105.
2008: Reinhard Stauder; Thomas Nösslinger; Michael Pfeilstöcker; Wolfgang R Sperr; Friedrich Wimazal; Otto Krieger; Peter Valent
Impact of age and comorbidity in myelodysplastic syndromes.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(9):927-34.
2008: Reinhard Stauder; Friedrich Wimazal; Thomas Nösslinger; Otto Krieger; Wolfgang R Sperr; Heinz Sill; Michael Pfeilstöcker; Peter Valent
[Individualized management and therapy of myelodysplastic syndromes].
Wiener klinische Wochenschrift 2008;120(17-18):523-37.
2006: Judith Loeffler-Ragg; Michael Steurer; H Ulmer; Sergej Skvortsov; B Kircher; Manfred Herold; Heinz Zwierzina; Reinhard Stauder
Elevated levels of serum CD44 and E-cadherin predict an unfavourable outcome in myelodysplastic syndromes.
Leukemia 2006;20(11):2064-7.
2005: Gerald Stifter; Simone Heiss; Guenther Gastl; Alexandar Tzankov; Reinhard Stauder
Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
European journal of haematology 2005;75(6):485-91.
2004: Wolfgang Eisterer; Oliver E Bechter; Ola Söderberg; Kenneth Nilsson; Maria Terol; richard greil; Josef Thaler; Manfred Herold; Lothar Finke; Ursula Günthert; Emilio Montserrat; Reinhard Stauder
Elevated levels of soluble CD44 are associated with advanced disease and in vitro proliferation of neoplastic lymphocytes in B-cell chronic lymphocytic leukaemia.
Leukemia research 2004;28(10):1043-51.
2003: Michael Steurer; Irene Sudmeier; Reinhard Stauder; Guenther Gastl
Thromboembolic events in patients with myelodysplastic syndrome receiving thalidomide in combination with darbepoietin-alpha.
British journal of haematology 2003;121(1):101-3.
2002: Michael Steurer; Reinhard Stauder; Kurt Grünewald; Eberhard Gunsilius; Hans-Christoph Duba; Guenther Gastl; Stephan Dirnhofer
Hepatosplenic gammadelta-T-cell lymphoma with leukemic course after renal transplantation.
Human pathology 2002;33(2):253-8.
2002: B Brunner; Eberhard Gunsilius; Petra Schumacher; Heinz Zwierzina; Guenther Gastl; Reinhard Stauder
Blood levels of angiogenin and vascular endothelial growth factor are elevated in myelodysplastic syndromes and in acute myeloid leukemia.
Journal of hematotherapy & stem cell research 2002;11(1):119-25.
2002: M van Driel; Ursula Günthert; A C van Kessel; P Joling; Reinhard Stauder; Henk M Lokhorst; Andries C Bloem
CD44 variant isoforms are involved in plasma cell adhesion to bone marrow stromal cells.
Leukemia 2002;16(1):135-43.
2001: Wolfgang Eisterer; Oliver E Bechter; Wolfgang Hilbe; M van Driel; Henk M Lokhorst; Josef Thaler; Andries C Bloem; Ursula Günthert; Reinhard Stauder
CD44 isoforms are differentially regulated in plasma cell dyscrasias and CD44v9 represents a new independent prognostic parameter in multiple myeloma.
Leukemia research 2001;25(12):1051-7.
2001: Johannes Clausen; Andreas L Petzer; Birgit Vergeiner; Martina Enk; Reinhard Stauder; Guenther Gastl; Eberhard Gunsilius
Optimal timing for the collection and in vitro expansion of cytotoxic CD56(+) lymphocytes from patients undergoing autologous peripheral blood stem cell transplantation.
Journal of hematotherapy & stem cell research 2001;10(4):513-21.
2001: Alexandar Tzankov; C Ludescher; Hans-Christoph Duba; M Steinlechner; R Knapp; Thomas Schmid; Kurt Grünewald; Guenther Gastl; Reinhard Stauder
Spontaneous remission in a secondary acute myelogenous leukaemia following invasive pulmonary aspergillosis.
Annals of hematology 2001;80(7):423-5.
1999: Oliver E Bechter; Wolfgang Eisterer; Stephan Dirnhofer; Georg Pall; Thomas Kühr; Reinhard Stauder; Josef Thaler
Expression of LFA-1 identifies different prognostic subgroups in patients with advanced follicle center lymphoma (FCL).
Leukemia research 1999;23(5):483-8.
1998: M van Driel; Ursula Günthert; Reinhard Stauder; P Joling; Henk M Lokhorst; Andries C Bloem
CD44 isoforms distinguish between bone marrow plasma cells from normal individuals and patients with multiple myeloma at different stages of disease.
Leukemia 1998;12(11):1821-8.
1998: S Legras; Ursula Günthert; Reinhard Stauder; F Curt; S Oliferenko; H C Kluin-Nelemans; J P Marie; S Proctor; Claude Jasmin; Florence Smadja-Joffe
A strong expression of CD44-6v correlates with shorter survival of patients with acute myeloid leukemia.
Blood 1998;91(9):3401-13.
1998: Ursula Günthert; Christoph Schwärzler; B Wittig; Jon D Laman; P Ruiz; Reinhard Stauder; Andries C Bloem; Florence Smadja-Joffe; Margot Zöller; Antonius G Rolink
Functional involvement of CD44, a family of cell adhesion molecules, in immune responses, tumour progression and haematopoiesis.
Advances in experimental medicine and biology 1998;451():43-9.
1996: Reinhard Stauder; M Van Driel; Christoph Schwärzler; Josef Thaler; Henk M Lokhorst; Ernst D Kreuser; Andries C Bloem; Ursula Günthert; Wolfgang Eisterer
Different CD44 splicing patterns define prognostic subgroups in multiple myeloma.
Blood 1996;88(8):3101-8.
1996: W Eistere; Wolfgang Hilbe; Reinhard Stauder; Oliver E Bechter; Falko Fend; Josef Thaler
An aggressive subtype of B-CLL is characterized by strong CD44 expression and lack of CD11c.
British journal of haematology 1996;93(3):661-9.
1996: Michael Unterhalt; R Herrmann; Markus Tiemann; Reza Parwaresch; Harald Stein; L Trümper; M Nahler; Monika A Reuss-Borst; C Tirier; A Neubauer; Mathias Freund; Ernst D Kreuser; H Dietzfelbinger; H Bodenstein; A Engert; Reinhard Stauder; Hartmut Eimermacher; K Landys; Wolfgang Hiddemann
Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study Group.
Leukemia 1996;10(5):836-43.
1995: Reinhard Stauder; Wolfgang Eisterer; Josef Thaler; Ursula Günthert
CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor.
Blood 1995;85(10):2885-99.
1995: Ursula Günthert; Reinhard Stauder; B Mayer; Hans-Joachim Terpe; Lothar Finke; KH Friedrichs
Are CD44 variant isoforms involved in human tumour progression?
Cancer surveys 1995;24():19-42.
1994: C R Mackay; Hans-Joachim Terpe; Reinhard Stauder; WL Marston; H Stark; Ursula Günthert
Expression and modulation of CD44 variant isoforms in humans.
The Journal of cell biology 1994;124(1-2):71-82.
1993: Reinhard Stauder; S Hamader; B Fasching; Georg Kemmler; Josef Thaler; Heinz Huber
Adhesion to high endothelial venules: a model for dissemination mechanisms in non-Hodgkin's lymphoma.
Blood 1993;82(1):262-7.
1993: Josef Thaler; Kurt Grünewald; C Gattringer; A D Ho; K Weyrer; O Dietze; Reinhard Stauder; T Fluckinger; A Lang; Heinz Huber
Long-term follow-up of patients with hairy cell leukaemia treated with pentostatin: lymphocyte subpopulations and residual bone marrow infiltration.
British journal of haematology 1993;84(1):75-82.
1991: Josef Thaler; O Dietze; H Denz; R Demuth; David Nachbaur; Reinhard Stauder; Heinz Huber
Bone marrow diagnosis in lymphoproliferative disorders: comparison of results obtained from conventional histomorphology and immunohistology.
Histopathology 1991;18(6):495-504.
1989: Reinhard Stauder; richard greil; T F Schulz; Josef Thaler; C Gattringer; T Radaskiewicz; M P Dierich; Heinz Huber
Expression of leucocyte function-associated antigen-1 and 7F7-antigen, an adhesion molecule related to intercellular adhesion molecule-1 (ICAM-1) in non-Hodgkin lymphomas and leukaemias: possible influence on growth pattern and leukaemic behaviour.
Clinical and experimental immunology 1989;77(2):234-8.
1988: T F Schulz; W Vogetseder; Manfred Mitterer; H P Neumayer; B L Myones; Reinhard Stauder; richard greil; Günther Böck; H Feichtinger; Heinz Huber
Importance of an 85 kDa membrane glycoprotein for a variety of cell-cell interactions.
Molecular immunology 1988;25(11):1053-61.
1988: A L Petzer; T F Schulz; Reinhard Stauder; A Eigentler; B L Myones; Manfred P Dierich
Structural and functional analysis of CR2/EBV receptor by means of monoclonal antibodies and limited tryptic digestion.
Immunology 1988;63(1):47-53.